Trial intelligence / Profile preview

Dose Response of Inhaled Fluticasone Propionate in COPD

NCT00995475Phase 4Completed

Sponsor
University of Dundee
Start
Oct 2006
Primary completion
Nov 2008
Modality
Orthosteric Ligands
01

Overview

A Phase 4 trial of fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by University of Dundee. Started Oct 2006; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00995475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00995475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call